On this page
What each program costs in Kansas
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the Kansas State Employee Health Plan (SEHP) cover GLP-1s for weight loss?
Kansas's State Employee Health Plan covers GLP-1s for weight management with Caremark prior authorization and, for prescriptions issued or renewed after January 1, 2026, a BMI of 35 or higher. Wegovy is the preferred drug; Zepbound needs a failed or unsuitable preferred drug first.
Kansas State Employee Health Plan
The SEHP's GLP-1 page sets a BMI of 35 or higher for weight-management coverage.
“Patients must have a Body Mass Index (BMI) of 35 or higher to qualify for coverage of GLP-1s for weight management.”
https://sehp.healthbenefitsprogram.ks.gov/glp-1s · read Oct 29, 2026
Kansas State Employee Health Plan
The BMI rule applies to prescriptions issued or renewed after January 1, 2026.
“This criterion applies to all GLP-1 prescriptions for weight management issued or renewed after Jan. 1, 2026.”
https://sehp.healthbenefitsprogram.ks.gov/glp-1s · read Oct 29, 2026
Kansas State Employee Health Plan
Every anti-obesity medication needs Caremark prior authorization.
“All Anti-Obesity Medications require prior authorization by Caremark.”
https://sehp.healthbenefitsprogram.ks.gov/glp-1s · read Oct 29, 2026
Kansas State Employee Health Plan
The page names Wegovy as the preferred GLP-1 for weight management.
“Wegovy® is currently the Preferred GLP-1 for weight management.”
https://sehp.healthbenefitsprogram.ks.gov/glp-1s · read Oct 29, 2026
Does Kansas Medicaid (KanCare) cover GLP-1s for weight loss?
Covered, with conditions
Kansas Medicaid's anti-obesity criteria list Wegovy and Zepbound for weight management with prior authorization, so it has a coverage path for weight loss. Read from state documents Nov 6, 2026.
What Kansas Medicaid (KanCare)'s documents say about each drug for weight loss. Read Nov 6, 2026. Kansas Department of Health and Environment, Division of Health Care Finance.
WegovyYes
Prior authorization. Adults: BMI 30 or higher, or 27 or higher with a weight-related condition. Age 12 to 17: BMI at the 95th percentile or higher. A lifestyle plan is required.
“Semaglutide (Wegovy®, Wegovy® HD) Weight Management”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Nov 1, 2026 · read Nov 6, 2026
“BMI ≥ 27 kg/m2 AND has at least one weight-related comorbidity listed in Table 2.”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Nov 1, 2026 · read Nov 6, 2026
“Patient must currently meet one of the following (some agents have additional criteria to meet)”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Nov 1, 2026 · read Nov 6, 2026
ZepboundYes
Prior authorization, age 18 or older. BMI 30 or higher, or 27 or higher with a weight-related condition. A lifestyle plan is required.
“Tirzepatide (Zepbound®) Weight Management”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Nov 1, 2026 · read Nov 6, 2026
“BMI ≥ 27 kg/m2 AND has at least one weight-related comorbidity listed in Table 2.”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Nov 1, 2026 · read Nov 6, 2026
“Patient must currently meet one of the following (some agents have additional criteria to meet)”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Nov 1, 2026 · read Nov 6, 2026
OzempicNo
Criteria list type 2 diabetes uses, including heart and kidney risk in adults with type 2 diabetes.
“Semaglutide (Ozempic®) Adjunct to diet and exercise to improve glycemic control in T2DM (noninsulin dependent)”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Apr 16, 2025 · read Nov 6, 2026
MounjaroNo
Criteria list blood sugar control in type 2 diabetes for adults.
“Tirzepatide (Mounjaro®) Adjunct to diet and exercise to improve glycemic control in T2DM (noninsulin dependent)”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Apr 16, 2025 · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Kansas Department of Health and Environment, Division of Health Care Finance documents. KFF's January 2026 map listed this program as covered; the documents we read agree.
- Jun 1, 2025 · Policy changeWegovy stopped needing the extra high-cost criteria for severe obesity.
“Note: This section does not apply for the following drugs: Zepbound®(as of 4/1/24), Wegovy®(as of 6/1/25)”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Jun 1, 2025 · read Nov 6, 2026
- Apr 1, 2024 · Policy changeZepbound stopped needing the extra high-cost criteria for severe obesity.
“Note: This section does not apply for the following drugs: Zepbound®(as of 4/1/24), Wegovy®(as of 6/1/25)”
Kansas Department of Health and Environment, Division of Health Care Finance, PA Criteria · Effective Apr 1, 2024 · read Nov 6, 2026
Weight loss
Covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
33,127 prescriptions
Ozempic and Mounjaro, 2025
14,551 prescriptions
Neighbours covering weight loss
1 of 4
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Kansas Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Kansas Medicaid as "covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Kansas Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Kansas Medicaid pay for?
50,850 GLP-1 prescriptions in 2025, 36th of the 50 states and DC, with $52.1 million reimbursed before rebates. Counting the share other payers covered, $53.5 million.
Prescriptions, 2025
50,850
36th of 51
Medicaid paid
$52.1M
34th of 51, before rebates
Per prescription
$1,025
$1,051 nationally
Weight-loss brands
65%
1st highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Kansas is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 65% of Kansas Medicaid's GLP-1 prescriptions in 2025 (33,127). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Zepbound was Kansas Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Zepboundapproved for weight management | 26,959 | 53% | $27.9 million | $1,034 |
| Mounjaro | 7,455 | 15% | $7.3 million | $980 |
| Ozempic | 7,096 | 14% | $6.5 million | $915 |
| Wegovyapproved for weight management | 6,022 | 12% | $7.6 million | $1,257 |
| Trulicity | 2,651 | 5.2% | $2.4 million | $906 |
| Liraglutide (generic) | 368 | 0.7% | $185,570 | $504 |
| Rybelsus | 153 | 0.3% | $141,864 | $927 |
| Saxendaapproved for weight management | 146 | 0.3% | $171,806 | $1,177 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in Kansas?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 1 in Kansas. The register does not say which, if any, supplies a program on this page.
- Fagron Compounding Services dba Fagron Sterile Services, Wichita. Registered since Oct 2, 2015; last FDA inspection Aug 8, 2025.
On Medicare in Kansas?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Kansas and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
1 of the 4 states next to Kansas covers GLP-1s for weight loss through Medicaid: Missouri. None has a lower cash floor than Kansas's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Kansas | Covered | 19 | $39/mo |
| Colorado | Not covered | 19 | $39/moWellmedr |
| Missouri | Zepbound only | 18 | $39/moWellmedr |
| Nebraska | Not covered | 19 | $39/moWellmedr |
| Oklahoma | Not covered | 19 | $39/moWellmedr |






















